NEK9 Antibody (YA1362)

(Synonyms: NC; APUG; NERCC; LCCS10; NERCC1)
1 Cited Publications
Customer Review

Based on 1 publication(s) in Google Scholar

NEK9 Antibody (YA1362) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to NEK9.

For research use only. We do not sell to patients.
  • Host:

    Rabbit

  • Isotype:

    IgG

  • Application:

    WB, IHC-F, IHC-P, ICC/IF

  • Reactivity :

    Human, Rat

  • Formulation:

    Supplied in 50mM Tris-Glycine(pH 7.4), 0.15M NaCl, 40% Glycerol, 0.01% Sodium azide and 0.05% BSA

  • Conjugation:
    Non-conjugated

Publications Citing Use of MedChemExpress (MCE) NEK9 Antibody (YA1362)

More

Applications

Application
WB Info
WB: Western Blot
IHC-P Info
IHC-P: Immunohistochemistry-Paraffin
IHC-F Info
IHC-F: Immunohistochemistry-Frozen
ICC/IF Info
ICC/IF: Immunocytochemistry/
Immunofluorescence
Dilution Ratio 1:500-1:1000 1:50-1:100 1:50-1:100 1:50-1:200

Product Details

Description

NEK9 Antibody (YA1362) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to NEK9.

  • Host Rabbit
  • Clonality Recombinant,Monoclonal
  • Species Reactivity
    Human, Rat
  • Observed Molecular Weight
    Observed band size: 107 kDa Info
    Note: Due to possible protein modifications or aggregation, the molecular weight should be confirmed by actual measurement, and the predicted value is for reference only.
  • Calculated Molecular Weight Predicted band size: 107 kDa
Species Reactivity Database
Immunogen

A synthetic peptide of human NEK9 aa1-15.

Sensitivity

Endogenous

Purification

Affinity Purified

Conjugation

Non-conjugated

Modification

Unmodified

Isotype

IgG

RRID

AB_3103727

Product Properties

  • Appearance

    Solution

  • Formulation

    Supplied in 50mM Tris-Glycine(pH 7.4), 0.15M NaCl, 40% Glycerol, 0.01% Sodium azide and 0.05% BSA

  • Concentration

    Batch-dependent, Please check the COA for the concentration of each lot. Check Lot Concentration

  • Storage & Stability

    Stored at -20°C for 1 year. Avoid repeated freeze / thaw cycles.

  • Shipping

    Shipping with blue ice.

Verification Images

  • Experimental Validation Results for NEK9 Antibody (YA1362)
    Immunohistochemical analysis of paraffin-embedded human rectum cancer tissue using NEK9 Antibody (HY-P81617, 1/100). The section was pretreated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0) for 8 minutes. The tissues were blocked with quick block buffer for 0.5 hours at room temperature, washed with PBS and PBST, and then incubated with the primary antibody overnight at 4℃. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX.
  • Experimental Validation Results for NEK9 Antibody (YA1362)
    Immunohistochemical analysis of paraffin-embedded human breast cancer tissue using NEK9 Antibody (HY-P81617, 1/100). The section was pretreated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0) for 8 minutes. The tissues were blocked with quick block buffer for 0.5 hours at room temperature, washed with PBS and PBST, and then incubated with the primary antibody overnight at 4℃. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX.
  • Experimental Validation Results for NEK9 Antibody (YA1362)
    Immunohistochemical analysis of paraffin-embedded human thyroid cancer tissue using NEK9 Antibody (HY-P81617, 1/100). The section was pretreated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0) for 8 minutes. The tissues were blocked with quick block buffer for 0.5 hours at room temperature, washed with PBS and PBST, and then incubated with the primary antibody overnight at 4℃. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX.
  • Experimental Validation Results for NEK9 Antibody (YA1362)
    Immunohistochemical analysis of paraffin-embedded human prostate cancer tissue using NEK9 Antibody (HY-P81617, 1/100). The section was pretreated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0) for 8 minutes. The tissues were blocked with quick block buffer for 0.5 hours at room temperature, washed with PBS and PBST, and then incubated with the primary antibody overnight at 4℃. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX.
  • Experimental Validation Results for NEK9 Antibody (YA1362)
    Immunohistochemical analysis of paraffin-embedded human lung cancer tissue using NEK9 Antibody (HY-P81617, 1/100). The section was pretreated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0) for 8 minutes. The tissues were blocked with quick block buffer for 0.5 hours at room temperature, washed with PBS and PBST, and then incubated with the primary antibody overnight at 4℃. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX.
  • Experimental Validation Results for NEK9 Antibody (YA1362)
    Immunohistochemical analysis of paraffin-embedded human glioma tissue using NEK9 Antibody (HY-P81617, 1/100). The section was pretreated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0) for 8 minutes. The tissues were blocked with quick block buffer for 0.5 hours at room temperature, washed with PBS and PBST, and then incubated with the primary antibody overnight at 4℃. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX.
  • Experimental Validation Results for NEK9 Antibody (YA1362)
    Immunohistochemical analysis of paraffin-embedded human tonsil tissue using NEK9 Antibody (HY-P81617, 1/100). The section was pretreated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0) for 8 minutes. The tissues were blocked with quick block buffer for 0.5 hours at room temperature, washed with PBS and PBST, and then incubated with the primary antibody overnight at 4℃. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX.
  • Experimental Validation Results for NEK9 Antibody (YA1362)
    Immunohistochemical analysis of paraffin-embedded human endometrium tissue using NEK9 Antibody (HY-P81617, 1/100). The section was pretreated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0) for 8 minutes. The tissues were blocked with quick block buffer for 0.5 hours at room temperature, washed with PBS and PBST, and then incubated with the primary antibody overnight at 4℃. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX.
  • Experimental Validation Results for NEK9 Antibody (YA1362)
    Immunohistochemical analysis of paraffin-embedded human adrenal gland tissue using NEK9 Antibody (HY-P81617, 1/100). The section was pretreated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0) for 8 minutes. The tissues were blocked with quick block buffer for 0.5 hours at room temperature, washed with PBS and PBST, and then incubated with the primary antibody overnight at 4℃. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX.
  • Experimental Validation Results for NEK9 Antibody (YA1362)
    Immunocytochemistry analysis of NIH/3T3 cells labeling NEK9 with NEK9 Antibody (HY-P81617) at 1/50 dilution. Cells were fixed in 4% paraformaldehyde for 15 minutes at room temperature, then blocked with QuickBlock™ Blocking Buffer for Immunol Staining for 10 min at room temperature. Cells were then incubated with NEK9 Antibody (HY-P81617) at 1/50dilution in QuickBlock™ Blocking Buffer for Immunol Staining at 4 ℃. Alexa Fluor® 488-conjugated AffiniPure Goat Anti-Rabbit IgG H&L(HY-P8002, Green) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. The Nuclear counterstain was DAPI (Blue).
  • Experimental Validation Results for NEK9 Antibody (YA1362)
    Immunocytochemistry analysis of NIH/3T3 cells labeling NEK9 with NEK9 Antibody (HY-P81617) at 1/100 dilution. Cells were fixed in 4% paraformaldehyde for 15 minutes at room temperature, then blocked with QuickBlock™ Blocking Buffer for Immunol Staining for 10 min at room temperature. Cells were then incubated with NEK9 Antibody (HY-P81617) at 1/100dilution in QuickBlock™ Blocking Buffer for Immunol Staining at 4 ℃. Alexa Fluor® 488-conjugated AffiniPure Goat Anti-Rabbit IgG H&L(HY-P8002, Green) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. The Nuclear counterstain was DAPI (Blue).

Background

  • Function

    NEK9 (NIMA-related kinase 9) is a serine/threonine kinase that functions as a central regulator of mitotic progression by coordinating centrosome dynamics, spindle assembly, and chromosome segregation through a conserved NEK9-NEK6/NEK7 signaling module[1][2]. Mechanistically, NEK9 is activated during early mitosis through sequential regulation by CDK1 and PLK1, enabling downstream activation of NEK6 and NEK7 and promoting proper spindle organization and centrosome separation[1]. NEK9 further contributes to centrosome maturation through direct regulation of NEDD1 and recruitment of γ-tubulin-associated microtubule nucleation machinery, linking centrosome function with efficient bipolar spindle formation[2]. As a result, disruption of NEK9 activity causes defects in spindle assembly, mitotic progression, and chromosome segregation in cellular and experimental systems[1][2]. In disease-relevant contexts, human NEK9 mutations have been associated with developmental abnormalities and abnormal embryonic outcomes, supporting an essential role in organismal development and genome stability[2]. Compared with the closely related kinases NEK6 and NEK7, which act primarily as downstream effectors, NEK9 occupies the upstream position of the signaling cascade and also performs functions that are independent of NEK6/NEK7 activation, particularly in centrosome maturation through NEDD1 regulation[2]. Therefore, NEK9 serves as a valuable experimental target for studies of mitotic control, centrosome biology, spindle assembly, and chromosome stability mechanisms[1][2].

  • Subcellular Localization

    Cytoplasm; Nucleus

  • Expression


    Tissue_specificity:Most abundant in heart, liver, kidney and testis. Also expressed in smooth muscle cells and fibroblasts

  • Subunit

    Homodimer; homodimerization is required to activate NEK7 (PubMed:23482567, PubMed:26522158). Binds to Ran GTPase (PubMed:12101123). Has a greater affinity for Ran-GDP over Ran-GTP (PubMed:12101123). Interacts with SSRP1 and SUPT16H, the 2 subunits of the FACT complex (PubMed:14660563). Interacts with DYNLL1; phosphorylation at Ser-944 strongly reduces DYNLL1 binding (PubMed:23482567)

  • SwissProt ID

    Q8TD19

  • Gene ID
  • Synonyms

    NC; APUG; NERCC; LCCS10; NERCC1

  • Research Field

    Cell Biology

References

NEK9 Antibody (YA1362) Related Classifications

MOQ
Minimum order quantity
100 mg

Get Quote In-stock

Other size
Get Quote
Please select quantity
Amount: USD 0.00